Sanofi (SAN.PA)
EUR 91.8
(0.07%)
EUR 91.8
(0.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.87 Billion EUR | -45.32% |
| 2022 | 16.79 Billion EUR | 106.67% |
| 2021 | 8.12 Billion EUR | 0.54% |
| 2020 | 8.08 Billion EUR | 5.04% |
| 2019 | 7.69 Billion EUR | -38.1% |
| 2018 | 12.43 Billion EUR | 3.53% |
| 2017 | 12 Billion EUR | -2.71% |
| 2016 | 12.34 Billion EUR | -2.91% |
| 2015 | 12.71 Billion EUR | 0.7% |
| 2014 | 12.62 Billion EUR | -2.97% |
| 2013 | 13.01 Billion EUR | -17.14% |
| 2012 | 15.7 Billion EUR | 173.97% |
| 2011 | 5.73 Billion EUR | -3.86% |
| 2010 | 5.96 Billion EUR | -6.36% |
| 2009 | 6.36 Billion EUR | -34.79% |
| 2008 | 9.76 Billion EUR | 64.89% |
| 2007 | 5.92 Billion EUR | 3.34% |
| 2006 | 5.72 Billion EUR | -23.06% |
| 2005 | 7.44 Billion EUR | 2935.33% |
| 2004 | -262.61 Million EUR | -108.55% |
| 2003 | 3.06 Billion EUR | 17.35% |
| 2002 | 2.61 Billion EUR | 24.21% |
| 2001 | 2.1 Billion EUR | 33.54% |
| 2000 | 1.57 Billion EUR | 62.41% |
| 1999 | 971 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.03 Billion EUR | -63.95% |
| 2024 Q2 | 1.62 Billion EUR | -19.88% |
| 2024 Q3 | 3.63 Billion EUR | 123.28% |
| 2023 Q3 | 3.21 Billion EUR | 72.73% |
| 2023 Q4 | 5.63 Billion EUR | 75.55% |
| 2023 Q1 | 4.13 Billion EUR | 19.38% |
| 2023 FY | 9.18 Billion EUR | -45.32% |
| 2023 Q2 | 1.85 Billion EUR | -55.09% |
| 2022 Q4 | 3.46 Billion EUR | -40.59% |
| 2022 Q1 | 3.7 Billion EUR | 26.77% |
| 2022 Q3 | 5.83 Billion EUR | 67.69% |
| 2022 FY | 16.79 Billion EUR | 106.67% |
| 2022 Q2 | 3.48 Billion EUR | -6.03% |
| 2021 Q3 | 4.31 Billion EUR | 41.21% |
| 2021 Q4 | 2.92 Billion EUR | -32.24% |
| 2021 FY | 8.12 Billion EUR | 0.54% |
| 2021 Q2 | 3.05 Billion EUR | -9.57% |
| 2021 Q1 | 3.37 Billion EUR | 21.26% |
| 2020 Q2 | 2.71 Billion EUR | -22.38% |
| 2020 FY | 8.08 Billion EUR | 5.04% |
| 2020 Q4 | 2.78 Billion EUR | 6.53% |
| 2020 Q1 | 3.49 Billion EUR | 124.33% |
| 2020 Q3 | 2.61 Billion EUR | -3.58% |
| 2019 Q4 | 1.55 Billion EUR | -59.07% |
| 2019 FY | 7.69 Billion EUR | -38.1% |
| 2019 Q3 | 3.8 Billion EUR | 11.73% |
| 2019 Q1 | 3.11 Billion EUR | 24.61% |
| 2019 Q2 | 3.4 Billion EUR | 9.16% |
| 2018 FY | 12.43 Billion EUR | 3.53% |
| 2018 Q3 | 4.21 Billion EUR | 51.26% |
| 2018 Q1 | 2.75 Billion EUR | 18.17% |
| 2018 Q2 | 2.78 Billion EUR | 1.13% |
| 2018 Q4 | 2.5 Billion EUR | -40.68% |
| 2017 Q4 | 2.33 Billion EUR | -33.14% |
| 2017 Q2 | 3.1 Billion EUR | -0.39% |
| 2017 Q1 | 3.11 Billion EUR | 3.04% |
| 2017 FY | 12 Billion EUR | -2.71% |
| 2017 Q3 | 3.49 Billion EUR | 12.41% |
| 2016 Q3 | 3.73 Billion EUR | 29.6% |
| 2016 Q4 | 3.02 Billion EUR | -19.06% |
| 2016 Q2 | 2.88 Billion EUR | -2.39% |
| 2016 Q1 | 2.95 Billion EUR | 241.2% |
| 2016 FY | 12.34 Billion EUR | -2.91% |
| 2015 Q2 | 3.34 Billion EUR | 0.27% |
| 2015 Q1 | 3.33 Billion EUR | 98.19% |
| 2015 Q3 | 3.65 Billion EUR | 9.17% |
| 2015 Q4 | 866 Million EUR | -76.31% |
| 2015 FY | 12.71 Billion EUR | 0.7% |
| 2014 Q3 | 3.59 Billion EUR | 14.11% |
| 2014 Q1 | 3.26 Billion EUR | -7.84% |
| 2014 Q4 | 1.68 Billion EUR | -53.17% |
| 2014 FY | 12.62 Billion EUR | -2.97% |
| 2014 Q2 | 3.15 Billion EUR | -3.52% |
| 2013 Q4 | 3.54 Billion EUR | -2.29% |
| 2013 FY | 13.01 Billion EUR | -17.14% |
| 2013 Q3 | 3.62 Billion EUR | 14.71% |
| 2013 Q2 | 3.16 Billion EUR | -9.95% |
| 2013 Q1 | 3.51 Billion EUR | 8.02% |
| 2012 FY | 15.7 Billion EUR | 173.97% |
| 2012 Q2 | 3.97 Billion EUR | 80.1% |
| 2012 Q3 | 4.44 Billion EUR | 11.95% |
| 2012 Q1 | 2.2 Billion EUR | 20.02% |
| 2012 Q4 | 3.25 Billion EUR | -26.87% |
| 2011 Q3 | 2.33 Billion EUR | 51.26% |
| 2011 FY | 5.73 Billion EUR | -3.86% |
| 2011 Q1 | 1.35 Billion EUR | 53.79% |
| 2011 Q2 | 1.54 Billion EUR | 13.62% |
| 2011 Q4 | 1.83 Billion EUR | -21.25% |
| 2010 Q1 | 1.98 Billion EUR | -74.51% |
| 2010 Q2 | 2.02 Billion EUR | 1.61% |
| 2010 Q3 | 1.71 Billion EUR | -15.15% |
| 2010 Q4 | 883 Million EUR | -48.48% |
| 2010 FY | 5.96 Billion EUR | -6.36% |
| 2009 Q2 | 2.17 Billion EUR | 7.55% |
| 2009 Q4 | 7.8 Billion EUR | 155900.0% |
| 2009 Q1 | 2.02 Billion EUR | 224.29% |
| 2009 FY | 6.36 Billion EUR | -34.79% |
| 2009 Q3 | 5 Million EUR | -99.77% |
| 2008 Q2 | 1.48 Billion EUR | -40.51% |
| 2008 Q3 | 2.58 Billion EUR | 74.49% |
| 2008 FY | 9.76 Billion EUR | 64.89% |
| 2008 Q4 | -1.63 Billion EUR | -162.96% |
| 2008 Q1 | 2.49 Billion EUR | 116.59% |
| 2007 Q1 | 7.05 Billion EUR | 143.83% |
| 2007 Q4 | -15.03 Billion EUR | -315.67% |
| 2007 Q3 | 6.96 Billion EUR | 324.78% |
| 2007 Q2 | 1.64 Billion EUR | -76.75% |
| 2007 FY | 5.92 Billion EUR | 3.34% |
| 2006 FY | 5.72 Billion EUR | -23.06% |
| 2006 Q4 | -16.09 Billion EUR | -318.87% |
| 2006 Q3 | 7.35 Billion EUR | 411.09% |
| 2006 Q2 | 1.43 Billion EUR | -49.11% |
| 2006 Q1 | 2.82 Billion EUR | 171.8% |
| 2005 Q1 | 4.02 Billion EUR | 140.2% |
| 2005 Q2 | 1.75 Billion EUR | -56.41% |
| 2005 FY | 7.44 Billion EUR | 2935.33% |
| 2005 Q4 | -3.93 Billion EUR | -206.86% |
| 2005 Q3 | 3.68 Billion EUR | 110.13% |
| 2004 Q4 | -10.01 Billion EUR | -287.64% |
| 2004 Q2 | 865.75 Million EUR | -61.13% |
| 2004 Q3 | 5.33 Billion EUR | 516.22% |
| 2004 Q1 | 2.22 Billion EUR | 169.76% |
| 2004 FY | -262.61 Million EUR | -108.55% |
| 2003 Q2 | 694.41 Million EUR | -64.31% |
| 2003 FY | 3.06 Billion EUR | 17.35% |
| 2003 Q4 | -3.19 Billion EUR | -232.07% |
| 2003 Q1 | 1.94 Billion EUR | 165.94% |
| 2003 Q3 | 2.41 Billion EUR | 248.12% |
| 2002 Q4 | -2.95 Billion EUR | -257.68% |
| 2002 FY | 2.61 Billion EUR | 24.21% |
| 2002 Q2 | 615.03 Million EUR | 0.0% |
| 2002 Q3 | 1.87 Billion EUR | 204.28% |
| 2001 FY | 2.1 Billion EUR | 33.54% |
| 2000 FY | 1.57 Billion EUR | 62.41% |
| 1999 FY | 971 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Virbac SA | 171.98 Million EUR | -4478.994% |